|
|
||||||||
From the Department of Ophthalmology, The Queens University of Belfast, The Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom.
PURPOSE. Vascular endothelial growth factor (VEGF)-A and placental growth factor (PlGF) are members of a large group of homologous peptides identified as the VEGF family. Although VEGF-A is known to act as a potent angiogenic peptide in the retina, the vasoactive function of PlGF in this tissue is less well defined. This study has sought to elucidate the expression patterns and modulatory role of these growth factors during retinal vascular development and hyaloid regression in the neonatal mouse.
METHODS. C57BL6J mice were killed at postnatal days (P)1, P3, P5, P7, P9, and P11. The eyes were enucleated and processed for in situ hybridization and immunocytochemistry and the retinas extracted for total protein or RNA. Separate groups of neonatal mice were also injected intraperitoneally daily from P2 through P9 with either VEGF-neutralizing antibody, PlGF-neutralizing antibody, isotype immunoglobulin (Ig)-G, or phosphate-buffered saline (PBS). The mice were then perfused with fluorescein isothiocyanate (FITC)-dextran, and the eyes were subsequently embedded in paraffin wax or flat mounted.
RESULTS. Quantitative (real-time) reverse transcription-polymerase chain reaction (RT-PCR) demonstrated similar expression patterns of VEGF-A and PlGF mRNA during neonatal retinal development, although the fluctuation between time periods was greater overall for VEGF-A. The localization of VEGF-A and PlGF in the retina, as revealed by in situ hybridization and immunohistochemistry, was also similar. Neutralization of VEGF-A caused a significant reduction in the hyaloid and retinal vasculature, whereas PlGF antibody treatment caused a marked persistence of the hyaloid without significantly affecting retinal vascular development.
CONCLUSIONS. Although having similar expression patterns in the retina, these growth factors appear to have distinct modulatory influences during normal retinal vascular development and hyaloid regression.
This article has been cited by other articles:
![]() |
N. F. Schafer, U. F. O. Luhmann, S. Feil, and W. Berger Differential Gene Expression in Ndph-Knockout Mice in Retinal Development Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 906 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Glenn, H. Mahaffy, K. Wu, G. Smith, R. Nagai, D. A. C. Simpson, M. E. Boulton, and A. W. Stitt Advanced Glycation End Product (AGE) Accumulation on Bruch's Membrane: Links to Age-Related RPE Dysfunction Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 441 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, S. Fuhrmann, and M. L. Vetter A Nonautonomous Role for Retinal Frizzled-5 in Regulating Hyaloid Vitreous Vasculature Development Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5561 - 5567. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Monte, M. Cammalleri, D. Martini, G. Casini, and P. Bagnoli Antiangiogenic Role of Somatostatin Receptor 2 in a Model of Hypoxia-Induced Neovascularization in the Retina: Results from Transgenic Mice Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3480 - 3489. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. de Gooyer, K. A. Stevenson, P. Humphries, D. A. C. Simpson, T. M. Curtis, T. A. Gardiner, and A. W. Stitt Rod Photoreceptor Loss in Rho-/- Mice Reduces Retinal Hypoxia and Hypoxia-Regulated Gene Expression Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5553 - 5560. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. de Gooyer, K. A. Stevenson, P. Humphries, D. A. C. Simpson, T. A. Gardiner, and A. W. Stitt Retinopathy Is Reduced during Experimental Diabetes in a Mouse Model of Outer Retinal Degeneration Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5561 - 5568. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshioka, T. Abe, R. Wakusawa, T. Moriya, S. Mochizuki, Y. Saigo, T. Saito, H. Murata, Y. Tokita, T. Iseya, et al. Recombinant AAV-Transduced Iris Pigment Epithelial Cell Transplantation May Transfer Vector to Native RPE but Suppress Systemic Dissemination Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 745 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Dhomen, K. S. Balaggan, R. A. Pearson, J. W. Bainbridge, E. M. Levine, R. R. Ali, and J. C. Sowden Absence of Chx10 Causes Neural Progenitors to Persist in the Adult Retina Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 386 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. F. O. Luhmann, J. Lin, N. Acar, S. Lammel, S. Feil, C. Grimm, M. W. Seeliger, H.-P. Hammes, and W. Berger Role of the Norrie Disease Pseudoglioma Gene in Sprouting Angiogenesis during Development of the Retinal Vasculature Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3372 - 3382. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Brown, L. Leamen, V. Cucevic, and F. S. Foster Quantitation of Hemodynamic Function during Developmental Vascular Regression in the Mouse Eye Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2231 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
C-M Lai, S A Dunlop, L A May, M Gorbatov, M Brankov, W-Y Shen, N Binz, Y K. Lai, C E Graham, C J Barry, et al. Generation of transgenic mice with mild and severe retinal neovascularisation Br. J. Ophthalmol., July 1, 2005; 89(7): 911 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. Zamora, M. H. Davies, S. R. Planck, J. T. Rosenbaum, and M. R. Powers Soluble Forms of EphrinB2 and EphB4 Reduce Retinal Neovascularization in a Model of Proliferative Retinopathy Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2175 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hahn, T. Lindsten, M. Tolentino, C. B. Thompson, J. Bennett, and J. L. Dunaief Persistent Fetal Ocular Vasculature in Mice Deficient in Bax and Bak Arch Ophthalmol, June 1, 2005; 123(6): 797 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ohlmann, M. Scholz, A. Goldwich, B. K. Chauhan, K. Hudl, A. V. Ohlmann, E. Zrenner, W. Berger, A. Cvekl, M. W. Seeliger, et al. Ectopic Norrin Induces Growth of Ocular Capillaries and Restores Normal Retinal Angiogenesis in Norrie Disease Mutant Mice J. Neurosci., February 16, 2005; 25(7): 1701 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Ohlmann, E. Adamek, A. Ohlmann, and E. Lutjen-Drecoll Norrie Gene Product Is Necessary for Regression of Hyaloid Vessels Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2384 - 2390. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |